27 related articles for article (PubMed ID: 24183880)
1. Assessment by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry of the Effects of Preanalytical Variables on Serum Peptidome Profiles Following Long-Term Sample Storage.
Tsuchida S; Satoh M; Umemura H; Sogawa K; Takiwaki M; Ishige T; Miyabayashi Y; Iwasawa Y; Kobayashi S; Beppu M; Nishimura M; Kodera Y; Matsushita K; Nomura F
Proteomics Clin Appl; 2018 May; 12(3):e1700047. PubMed ID: 29349874
[TBL] [Abstract][Full Text] [Related]
2. New serum biomarkers for detection of HBV-induced liver cirrhosis using SELDI protein chip technology.
Zhu XD; Zhang WH; Li CL; Xu Y; Liang WJ; Tien P
World J Gastroenterol; 2004 Aug; 10(16):2327-9. PubMed ID: 15285013
[TBL] [Abstract][Full Text] [Related]
3. [Salivary Peptide Profiling Analysis of Patients with Periodontitis and Chronic Obstructive Pulmonary Disease].
Wang L; Li XF; Zhang TY; Li W; Wang ZM; Lin M
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Jan; 54(1):91-96. PubMed ID: 36647649
[TBL] [Abstract][Full Text] [Related]
4. Serum lipidomic profiling for liver cancer screening using surface-assisted laser desorption ionization MS and machine learning.
Wu Q; Yu J; Zhang M; Xiong Y; Zhu L; Wei B; Wu T; Du Y
Talanta; 2024 Feb; 268(Pt 2):125371. PubMed ID: 37931569
[TBL] [Abstract][Full Text] [Related]
5. Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure.
Cao TH; Jones DJL; Quinn PA; Chan DCS; Hafid N; Parry HM; Mohan M; Sandhu JK; Anker SD; Cleland JG; Dickstein K; Filippatos G; Hillege HL; Metra M; Ponikowski P; Samani NJ; Van Veldhuisen DJ; Zannad F; Zwinderman AH; Voors AA; Lang CC; Ng LL
Clin Proteomics; 2018; 15():35. PubMed ID: 30410428
[TBL] [Abstract][Full Text] [Related]
6. The Difference Quantity of Urinary Peptides between Two Groups of Type 2 Diabetic Patients with or without Coronary Artery Disease.
Fu G; Hu M; Chu L; Zhang M
Int J Endocrinol; 2015; 2015():758402. PubMed ID: 26089891
[TBL] [Abstract][Full Text] [Related]
7. The liver matrisome - looking beyond collagens.
Arteel GE; Naba A
JHEP Rep; 2020 Aug; 2(4):100115. PubMed ID: 32637906
[TBL] [Abstract][Full Text] [Related]
8. ITIH4: Effective Serum Marker, Early Warning and Diagnosis, Hepatocellular Carcinoma.
Li X; Li B; Li B; Guo T; Sun Z; Li X; Chen L; Chen W; Chen P; Mao Y; Zeng Y
Pathol Oncol Res; 2018 Jul; 24(3):663-670. PubMed ID: 28828637
[TBL] [Abstract][Full Text] [Related]
9. Application Value of Mass Spectrometry in the Differentiation of Benign and Malignant Liver Tumors.
Li B; Li B; Guo T; Sun Z; Li X; Li X; Wang H; Chen W; Chen P; Qiao M; Xia L; Mao Y
Med Sci Monit; 2017 Apr; 23():1636-1644. PubMed ID: 28376075
[TBL] [Abstract][Full Text] [Related]
10. Human Antimicrobial Peptides in Bodily Fluids: Current Knowledge and Therapeutic Perspectives in the Postantibiotic Era.
Bastos P; Trindade F; da Costa J; Ferreira R; Vitorino R
Med Res Rev; 2018 Jan; 38(1):101-146. PubMed ID: 28094448
[TBL] [Abstract][Full Text] [Related]
11. LHBs can elevate the expression of MDR1 through HIF-1α in patients with CHB infection: a comparative proteomic study.
Li S; Yang Y; Ding X; Yang M; She S; Peng H; Xu X; Ran X; Li S; Hu P; Hu H; Zhang D; Ren H
Oncotarget; 2017 Jan; 8(3):4549-4562. PubMed ID: 27999186
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the raw serum peptidomic pattern in glioma patients.
Li Z; Lu H; Yang J; Zeng X; Zhao L; Li H; Liao Q; Peng S; Zhou M; Wu M; Xiang J; Wang Y; Li G
Clin Chim Acta; 2013 Oct; 425():221-6. PubMed ID: 23954773
[TBL] [Abstract][Full Text] [Related]
13. Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.
Liao J; Zhang R; Qian H; Cao L; Zhang Y; Xu W; Li J; Wu M; Yin Z
Biochem Biophys Res Commun; 2012 Apr; 420(2):308-14. PubMed ID: 22425980
[TBL] [Abstract][Full Text] [Related]
14. Detection of lung adenocarcinoma using magnetic beads based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry serum protein profiling.
Lin XL; Yang SY; Du J; Tian YX; Bu LN; Huo SF; Wang FP; Nan YD
Chin Med J (Engl); 2010 Jan; 123(1):34-9. PubMed ID: 20137572
[TBL] [Abstract][Full Text] [Related]
15. Datamining methodology for LC-MALDI-MS based peptide profiling.
Zucht HD; Lamerz J; Khamenia V; Schiller C; Appel A; Tammen H; Crameri R; Selle H
Comb Chem High Throughput Screen; 2005 Dec; 8(8):717-23. PubMed ID: 16464158
[TBL] [Abstract][Full Text] [Related]
16. The differential diagnostic model for serous peptidomics in HBV carriers established by MALDI-TOF-MS analysis.
Tian L; Wang Y; Xu D; Gao Y; Wen X; Tian Y
Clin Biochem; 2014 Jan; 47(1-2):56-62. PubMed ID: 24183880
[TBL] [Abstract][Full Text] [Related]
17. Serum peptide profiles during progression of chronic hepatitis B virus infection to liver failure.
Han T; Liu H; Yu ZL; Li J; Wang L; Xiao SX; Li Y; Yu ML
J Viral Hepat; 2010 Mar; 17 Suppl 1():18-23. PubMed ID: 20586930
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
